Skip to main content
Type at least 3 characters

539 articles

Original Research

Published on 19 Jun 2023

Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

in Cardiovascular Epidemiology and Prevention

  • Maciej Banach
  • Joanna Lewek
  • Kaja Pol
  • Daniel Rabczenko
  • Serban M. Balanescu
  • Vladimir Blaha
  • Richard Ceska
  • Piotr Jankowski
  • StanisĹ‚aw Surma
  • Genovefa Kolovou
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1206551
  • 2,769 views
  • 2 citations